Mf. Lechat et al., DECREASED SURVIVAL OF HTLV-I CARRIERS IN LEPROSY PATIENTS FROM THE DEMOCRATIC-REPUBLIC OF THE CONGO - A HISTORICAL PROSPECTIVE-STUDY, Journal of acquired immune deficiency syndromes and human retrovirology, 15(5), 1997, pp. 387-390
In this historical prospective study using sera stored for 22 years, w
e investigated the effect of HTLV-I infection on survival in a populat
ion of leprosy patients in the Democratic Republic of the Congo (forme
rly Zaire). We also determined the distribution of HTLV-I by subpopula
tion, age, and gender. Stored sera taken from a population of leprosy
patients and controls in 1969 were tested for HTLV-I. Follow-up surviv
al data on these patients were obtained in 1991. The sera collected in
1969 from 520 individuals was used to determine the prevalence of HTL
V-I. Included in this number were 328 patients resident in the sanator
ium. Survival and other data were available for 327 of these. A multiv
ariate survival analysis using a logistic regression model was perform
ed to evaluate the influence of HTLV-I status, age, type of leprosy, g
ender, duration of hospitalization, and ethnic group on survival. The
overall prevalence of HTLV-I among the 520 individuals in the prevalen
ce study was 34%, with 37.4% in the leprosy group and 25.2% in the con
trol group (p < 0.01). Multivariate analysis using logistic regression
showed that females of the Mongo and Ngombe ethnic group taken togeth
er were significantly more likely to be infected than the other groups
(OR = 3.67, 95% CI: 2.14 to 6.30). A comparison of the death rates di
rectly standardized for age and sex showed that the rate was significa
ntly higher for HTLV-I positive (5.5/100 person-years of observation)
compared with HTLV-I negative (3.6/100 person-years of observation). A
survival analysis using the Cox model showed a risk ratio of 1.4 (CI:
1.04 to 1.89) for those infected with HTLV-I. An increase in the deat
h rate was associated with HTLV-I infection in leprosy inpatients. The
decreased survival associated with HTLV-I infection may result from a
n increased susceptibility to a variety of diseases.